Hospital leadership suspended the facility’s toxicology program Feb. 26 after receiving a letter from insurer Anthem claiming SWMC was involved in a lab testing scheme. However, leaders reportedly did not inform PDHCD or the public of the program’s suspension for roughly one month, the report states. PDHCD owns the facility occupied and leased by SWMC, a separate nonprofit entity.
PDHCD Board Member Jim Horn told the publication he attended four board meetings after the toxicology program was suspended Feb. 26. He said no SWMC executive or district official ever mentioned the program’s suspension during any of the four meetings.
Mr. Horn said he received an email March 29 canceling two board meetings typically scheduled for the first Monday of the month. Two special board meetings were announced the same day, one of which was open to the public. However, following public requests to learn more about the toxicology program’s closure, officials declined to provide any answers, according to the report.
To access the report, click here.
More articles on physician integration issues:
Michigan State medical school grad: Former Dean Dr. William Strampel ‘put it out there that I slept my way through medical school’
Johns Hopkins ends tradition of short white lab coats for first-year residents: 5 things to know
Why men are considered a ‘diversity pick’ for some OB-GYN residency programs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.